Dahlström-King L, Plaa G L
Département de pharmacologie, Faculté de médecine, Université de Montréal, Québec, Canada.
Biochem Pharmacol. 1989 Aug 1;38(15):2543-9. doi: 10.1016/0006-2952(89)90100-7.
Taurolithocholate, lithocholate, and a manganese-bilirubin combination produced a rapid reduction in bile flow after i.v. injection in the rat. The effect was diminished or blocked completely by pretreating the animals with cycloheximide or ethionine, known inhibitors of protein synthesis. The injection sequence and time period between administration of the inhibitor of protein synthesis and the cholestatic agent influenced the degree to which they modulated the cholestatic effect. The results indicate that uninterrupted protein synthesis is required for the expression of maximal reduction of bile flow by taurolithocholate, lithocholate, and a manganese-bilirubin combination.
牛磺石胆酸盐、石胆酸盐以及锰与胆红素的组合在大鼠静脉注射后可使胆汁流量迅速减少。用环己酰亚胺或乙硫氨酸(已知的蛋白质合成抑制剂)预处理动物后,这种作用会减弱或完全被阻断。蛋白质合成抑制剂与胆汁淤积剂给药之间的注射顺序和时间段会影响它们对胆汁淤积作用的调节程度。结果表明,牛磺石胆酸盐、石胆酸盐以及锰与胆红素的组合要使胆汁流量最大程度减少,需要不间断的蛋白质合成。